Related Experiment Videos
Endoluminal stent-graft stabilization for thoracic aortic dissection.
Daniel R Nathanson1, Julio A Rodriguez-Lopez, Venkatesh G Ramaiah
1Department of Cardiovascular and Endovascular Surgery, Arizona Heart Institute and Arizona Heart Hospital, Phoenix, Arizona, USA.
Summary
Thoracic endografting for type B aortic dissection shows promising early results. This stent-graft repair offers acceptable morbidity and mortality, potentially reducing aortic expansion and rupture risks.
Area of Science:
- Vascular Surgery
- Cardiovascular Research
- Medical Device Technology
Background:
- Type B aortic dissection presents significant challenges in thoracic aorta management.
- Traditional surgical repair carries substantial risks.
- Endovascular solutions are increasingly explored for complex aortic pathologies.
Purpose of the Study:
- To evaluate the safety and efficacy of thoracic endografting for type B aortic dissection.
- To assess the performance of the TAG Endoprosthesis in this patient cohort.
- To review early clinical outcomes and complications.
Main Methods:
- Retrospective analysis of prospectively collected data (March 2000-July 2004).
- Investigational device exemption protocol for the TAG thoracic endograft.
- 40 patients with type B aortic dissection treated with thoracic endografts.
Main Results:
- Technical success rate of 95% achieved.
- Low perioperative mortality (2.5%) and manageable endoleaks.
- Postoperative complications occurred in 38% of patients, including one case of paraplegia.
- One-year survival rate was 85%.
- Significant reduction in size of aneurysmal segments observed in 8 patients.
Conclusions:
- Thoracic endografting is a viable option for type B aortic dissection with acceptable outcomes.
- The TAG Endoprosthesis demonstrates potential in managing thoracic aortic pathologies.
- Stent-graft repair may reduce the incidence of thoracic aortic expansion and rupture.